Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValereum Plc Regulatory News (VLRM.PL)

Share Price Information for Valereum Plc (VLRM.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.27    -0.06 (-2.58%)
Bid:
2.24
Ask:
2.30
Spread: 0.06 (2.679%)
Market Cap: £12.31m
VLRM.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Valereum Plc Share Chart

Change of Directors

26 Oct 2023 08:13

RNS Number : 3937R
Valereum PLC
26 October 2023

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")

26 October 2023

Valereum Plc

("Valereum" or the "Company")

Change of Directors

Valereum Plc (AQSE: VLRM), the Gibraltar technology group, announces that James Formolli has been appointed as Chairman of the Company and that Richard Poulden has resigned as Chairman and director of the Company, Jack Sun has resigned as Finance Director with immediate effect. Alan Gravett has agreed to remain a director until Monday, 30th October 2023 to keep the Company legally compliant but has resigned as Non-Executive Director with effect from that date.

The board changes have been made to promote the best interests of the company and its shareholders. It is intended that additional board members will be appointed in the near future and a further announcement of their identities and of the composition of the corporate governance committees will be made once these appointments have been finalised.

James Formolli is an entrepreneur with 35 years of experience in capital raising, aviation, property development and investment. He has long standing links with Gibraltar, having co-founded Chestertons Estate Agents in 2005 as well as partnering with a large Gibraltar based property fund.

Richard Poulden said: "I welcome James' appointment and wish him every success."

James Formolli said: "I am pleased to become the new Chairman and I look forward to working with all stakeholders. On behalf of Valereum and its shareholders I would like to take this opportunity to thank Richard and his colleagues for their service to the company and to wish him every success in his future endeavours."

The following information is provided for the purpose of Rule 4.9 of the AQSE Growth Market Access Rulebook for James Formolli.? James Formolli holds an interest of 4,900,000 Ordinary Shares in the Company, representing approximately 5.07% of the issued share capital of the Company.

Current directorships and/or partnerships:

Former directorships and/or partnerships (within the last five years):

THE NICE GROUP LTD (09881450)

THE NICE TRADE LTD (11162005)

MALTRAVERS ROAD LTD (10891628)

PIER RD LTD (12344801)

POSSINGWORTH BARNS LTD (11704296)

STONEBRIDGE HOUSE LIMITED (13354594)

118 PORTLAND ROAD LTD (11255511) (in liquidation as dormant)

RJ PROPERTY HOLDINGS LIMITED (10856662) (dissolved)

STANFORD AND SAVILLE LTD (10823525)

CUMNOR HOUSE SCHOOL TRUST (02411055)

There is no further information to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.

The Directors of the Company accept responsibility for the contents of this announcement.

END

Enquiries:

Valereum Plc

James Formolli, Chairman

Tel: +971 4584 6284

AQSE Corporate Adviser

First Sentinel Corporate Finance

Brian Stockbridge

Tel: +44 20 3855 5551

Investor Relations

Soho Communications Ltd

George Hudson

Tel: +44 (0)7803 603130

george@sohocommunications.co.uk

For more information, please visit the Company's website at valereum.gi

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXUNABROAURURA
Date   Source Headline
5th Jun 20264:32 pmRNS-RValereum Vox Issue 4 Published
1st Jun 20267:00 amRNSHolding(s) in Company
22nd May 20263:00 pmRNS-RValereum Vox Issue 3 Published
15th May 20267:00 amRNSPlacing and Subscription Raising £1,050,000
11th May 20264:10 pmRNS-RValereum Vox Issue 2 Published
23rd Apr 20261:45 pmRNS-RLaunch of new blog, Valereum Vox
22nd Apr 20267:00 amRNSDefinitive Agreement with QGP
21st Apr 20267:00 amRNSSettlement Agreement with Blubird
16th Apr 20267:00 amRNSDefinitive Agreement Update
10th Apr 20262:48 pmRNSReplacement - Coupon Payment Received
10th Apr 20262:07 pmRNSCoupon Payment Received
9th Apr 202611:32 amRNSShare Options and PDMR Dealings
31st Mar 20261:46 pmRNSInvestor Meeting
31st Mar 20267:31 amRNSProposed Strategic Integration and Coupon Payment
4th Mar 20267:00 amRNSOTCQB Approval
27th Feb 202610:53 amRNSVLRM Markets Organisational Update
25th Feb 20267:00 amRNSOption Agreement to Cancel 2 Million Warrants
16th Feb 20267:00 amRNSDirectorate Changes
16th Feb 20267:00 amRNSSigning of MoU with Integra Foundation
9th Feb 20267:00 amRNSSigning of MoU with RWA.io & Defactor
6th Feb 20267:00 amRNSChanges to Board of Directors
30th Jan 20262:00 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSSigning of MoU and Exercise of Warrants
27th Jan 20263:50 pmRNSHolding(s) in Company
26th Jan 20267:00 amRNSForward Strategy Update
21st Jan 20267:00 amRNSAgreement and Lifting of Suspension
22nd Dec 20257:00 amRNSContract
22nd Dec 20257:00 amRNSContract
17th Dec 20257:00 amRNSResignation of Corporate Adviser and Suspension
4th Dec 202510:56 amRNS-ROTC Application
2nd Dec 202510:34 amRNSUpdate on Capital Raise
25th Nov 20257:00 amRNSAgreement to Raise Capital
21st Nov 20257:00 amRNSExercise of Warrants
17th Nov 20257:00 amRNSCompletion of Subscription
14th Nov 20257:00 amRNSDeployment of DigiShares’ Tokenisation Platform
27th Oct 20257:00 amRNS-RCOINGT to List on VLRM Markets
10th Oct 20257:00 amRNSSubscription to Raise £600,000
7th Oct 20257:00 amRNSVLRM Markets’ Post Launch Update
1st Oct 20259:00 amRNSOption Agreement to Cancel 2m Warrants
25th Sep 20257:00 amRNSValereum Advances GATE Token Strategy
24th Sep 20254:47 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSInterim Results
19th Sep 20257:00 amRNS-RUpdate on Strategy Implementation
10th Sep 20257:00 amRNS-RVLRM to Co-host Exclusive Side Event at TOKEN2049
4th Sep 20257:00 amRNS-RCrypto and Multi Currency Payroll Solution
20th Aug 20251:00 pmRNS-RStrategic Collaboration with ZIGChain & DigiShares
18th Aug 20257:00 amRNS-RIndirect Investee Update
14th Aug 20257:00 amRNSResult of WRAP Retail Offer
11th Aug 20254:30 pmRNSWRAP Retail Offer for up to £100,000
11th Aug 20257:00 amRNSStrategic Investment in Metrikus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.